23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

1 month ago 7
ARTICLE AD BOX
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
Read Entire Article